• About us
• Contact

Advertisement

Person › Details

Andrew Curtis (NMS Group S.p.A.)

Curtis, Andrew (NMS Group 202208– Chief Strategy Officer before Artelus + GNS Healthcare + SUDA Pharma + Affimed)

 

	Organisation	NMS Group S.p.A.
	Group	NMS Group (Group)
	Former/major organisation	Affimed Inc.
	Group	Affimed (Group)
	Product	TandAb bispecific antibody
	Product 2	cancer immunotherapy (immuno-oncology, I-O)

Record changed: 2022-09-27

Advertisement

More documents for Andrew Curtis

• [1] NMS Group S.p.A.. (8/3/22). "Press Release: NMS Group S.p.A. Appoints Andrew Curtis as Chief Strategy Officer, Effective Immediately"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.